跳到正文

ARCH Venture Partners X Overage, L.P. 内部人交易:近期 SEC Form 4 交易

过去 18 个月,ARCH Venture Partners X Overage, L.P.(CIK 1768905)在 4 家公司共报告 16 笔 SEC Form 4 内部人交易(最近一笔 2026-11-02)。

日期公司身份类型股数市值
2026-11-02Aspen Neuroscience, Inc. (ASPE)10% 以上股东买入295,490$0
2026-11-02Aspen Neuroscience, Inc. (ASPE)10% 以上股东买入187,182$0
2026-11-02Aspen Neuroscience, Inc. (ASPE)10% 以上股东买入298,258$0
2026-11-02Aspen Neuroscience, Inc. (ASPE)10% 以上股东买入286,304$0
2026-11-02Aspen Neuroscience, Inc. (ASPE)10% 以上股东买入295,490$0
2026-11-02Aspen Neuroscience, Inc. (ASPE)10% 以上股东买入259,948$0
2026-11-02Aspen Neuroscience, Inc. (ASPE)10% 以上股东买入66,667$1.0M
2026-11-02Aspen Neuroscience, Inc. (ASPE)10% 以上股东买入298,258$0
2026-11-02Aspen Neuroscience, Inc. (ASPE)10% 以上股东买入286,304$0
2026-11-02Aspen Neuroscience, Inc. (ASPE)10% 以上股东买入66,666$999,990
2026-11-02Aspen Neuroscience, Inc. (ASPE)10% 以上股东买入214,355$0
2026-11-02Aspen Neuroscience, Inc. (ASPE)10% 以上股东买入1.2M$18.0M
2026-07-06Boundless Bio, Inc. (BOLD)10% 以上股东买入16,000$16,480
2026-07-06Boundless Bio, Inc. (BOLD)10% 以上股东卖出16,000$39,840
2025-10-29Neumora Therapeutics, Inc. (NMRA)10% 以上股东买入1.9M$5.0M
2025-08-01Prime Medicine, Inc. (PRME)10% 以上股东买入3.0M$10.0M

来源:SEC Form 4 申报文件 · 截至 2026-11-02